Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Reaffirms Their Buy Rating on Option Care Health (OPCH)

Tipranks - Tipranks - Wed Mar 4, 6:14AM CST

J.P. Morgan analyst Lisa Gill maintained a Buy rating on Option Care Health today and set a price target of $40.00.

Claim 70% Off TipRanks Premium

According to TipRanks, Gill is a 5-star analyst with an average return of 9.8% and a 61.54% success rate. Gill covers the Healthcare sector, focusing on stocks such as Cencora, Labcorp Holdings, and Option Care Health.

In addition to J.P. Morgan, Option Care Health also received a Buy from Barrington’s Michael Petusky in a report issued on February 26. However, on February 25, TipRanks – Google downgraded Option Care Health (NASDAQ: OPCH) to a Hold.

See Insiders’ Hot Stocks on TipRanks >>

Based on Option Care Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.47 billion and a net profit of $58.5 million. In comparison, last year the company earned a revenue of $1.35 billion and had a net profit of $60.13 million

Read More on OPCH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).